Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26468946 | 0.95 | GRM4 (0.32) | GRM4 | |
| SCHEMBL26470069 | 0.93 | GRM4 (0.33) | GRM4KDM4EL3MBTL1HPGDTSHR | |
| SCHEMBL26468944 | 0.90 | ATR (0.32) | — | |
| SCHEMBL26468930 | 0.88 | KDM4E (0.31) | KDM4EL3MBTL1HPGDTSHRRAB9A | |
| SCHEMBL26468508 | 0.85 | GRM4 (0.32) | GRM4KDM4EL3MBTL1HPGDTSHR | |
| SCHEMBL26470072 | 0.85 | KDM4E (0.31) | KDM4E | |
| SCHEMBL26468928 | 0.84 | GRM4 (0.31) | GRM4PDE4D | |
| SCHEMBL26468526 | 0.83 | KDM4E (0.31) | KDM4EL3MBTL1HPGDTSHRRAB9A | |
| SCHEMBL26468866 | 0.83 | GRM4 (0.30) | GRM4 | |
| SCHEMBL26468544 | 0.82 | KDM4E (0.31) | KDM4EL3MBTL1HPGDTSHRRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230137213-A1 | NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | PPOX, PAH, CRY2 | GRM4 4591/4885KDM4E 907/4885L3MBTL1 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.